ARCHIVES

FDA To Tighten Up Regulations On Anticancer Drug Combinations, Stop “Permissiveness”

This article is from The Cancer Letter archive.

Vol. 02 No. 36 | September 3, 1976

Download PDF Visit The Full Archive

Related Articles

DCPC Board Approves $40 Million In New Concepts, Including Three In Breast Cancer, One In Melanoma

October 12, 1984

FDA Approvals: Lymphoseek Label Updated to Include Head and Neck SCC

June 27, 2014

NCI subsidy of $2 million paid major expenses of rescheduled meeting.

April 15, 2005

Schmidt Attempted To Answer Critics

October 1, 1976

NCI Grants: UT Southwestern, M.D. Anderson Win Lung Cancer SPORE

December 6, 1996

In Brief: Visco Elected Chairman of DOD Panel; Breast Cancer Stamp Raises $4.9 Million

February 19, 1999